Taylor Kaser
YOU?
Author Swipe
View article: Putting SQuID on the menu: A subcutaneous insulin protocol for diabetic ketoacidosis
Putting SQuID on the menu: A subcutaneous insulin protocol for diabetic ketoacidosis Open
Beginning in 2021, we developed and implemented the SQuID (subcutaneous insulin in diabetic ketoacidosis [DKA]) protocol for low to moderate severity (LTM) DKA, treating these patients on a single inpatient Hospitalist‐run observation floo…
View article: Social Determinants of Health and Health Literacy in Emergency Patients with Diabetic Ketoacidosis
Social Determinants of Health and Health Literacy in Emergency Patients with Diabetic Ketoacidosis Open
Introduction: Social determinants of health (SDoH) and health literacy have been demonstrated to significantly impact health outcomes. As part of a study of diabetic ketoacidosis (DKA) treatment from the emergency department (ED), we asses…
View article: <scp>SQuID</scp> (subcutaneous insulin in diabetic ketoacidosis) <scp>II</scp>: Clinical and operational effectiveness
<span>SQuID</span> (subcutaneous insulin in diabetic ketoacidosis) <span>II</span>: Clinical and operational effectiveness Open
Objective We previously demonstrated safe treatment of low‐ to moderate‐severity (LTM) diabetic ketoacidosis (DKA) using the SQuID protocol (subcutaneous insulin in DKA) in a non–intensive care unit (ICU) observation setting, with decrease…
View article: A Regional Approach to Hospital-Based Violence Intervention Programs Through LOV
A Regional Approach to Hospital-Based Violence Intervention Programs Through LOV Open
Context: Community violence is an underaddressed public health threat. Hospital-based violence intervention programs (HVIPs) have been used to address the root causes of violence and prevent reinjury. Objective: In this article, we describ…